tiprankstipranks
Aurobindo Pharma Ltd (IN:AUROPHARMA)
:AUROPHARMA
India Market

Aurobindo Pharma Ltd (AUROPHARMA) Income Statement

Compare
0 Followers

Aurobindo Pharma Ltd Income Statement

Last quarter (Q1 2024), Aurobindo Pharma Ltd's total revenue was ₹75.67B, an increase of 11.43% from the same quarter last year. In Q1, Aurobindo Pharma Ltd's net income was ₹9.19B. See Aurobindo Pharma Ltd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
₹ 290.02B₹ 246.17B₹ 233.67B₹ 245.58B₹ 227.38B
Gross Profit
₹ 160.16B₹ 133.24B₹ 132.26B₹ 146.55B₹ 130.03B
Operating Expenses
₹ 55.66B₹ 108.10B₹ 99.28B₹ 101.79B₹ 90.61B
Depreciation and Amortization
₹ 14.92B₹ 12.45B₹ 11.27B₹ 10.55B₹ 9.67B
EBITDA
₹ 61.79B₹ 40.09B₹ 45.79B₹ 85.29B₹ 48.85B
Operating Income
₹ 104.50B₹ 25.51B₹ 33.06B₹ 44.54B₹ 39.40B
Other Income/Expenses
₹ -60.70B₹ -54.92B₹ -44.33B₹ -20.60B₹ -1.99B
Pretax Income
₹ 43.80B₹ 26.13B₹ 33.73B₹ 73.44B₹ 37.43B
Net Income
₹ 31.73B₹ 19.27B₹ 26.48B₹ 53.35B₹ 28.45B
Per Share Metrics
₹ ―₹ ―₹ ―₹ ―₹ ―
Basic EPS
₹ 54.16₹ 32.90₹ 45.20₹ 91.05₹ 48.56
Diluted EPS
₹ 54.15₹ 32.90₹ 45.20₹ 91.05₹ 48.56
Weighted Average Shares Outstanding
585.85M 585.94M 585.94M 585.94M 585.94M
Weighted Average Shares Outstanding (Diluted)
585.94M 585.94M 585.94M 585.94M 585.94M
Currency in INR

Aurobindo Pharma Ltd Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis